Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 123 entries
Sorted by: Best Match Show Resources per page
ADVANCING women academic faculty in STEM careers: The role of critical HRD in supporting diversity and inclusion

STEM and diversity

Hutchins HM, Kovach JV.
GSID: SVF8D5i_7HoJ
HM Hutchins, JV Kovach - Advances in Developing Human …, 2019 - journals.sagepub.com

… of STEM women and WoC faculty in rank, increased diversity of STEM faculty applicants, improved diversity and … , and expanded access and availability of diversity resources and data. …

Cite
Hutchins, H. M., & Kovach, J. V. (2019). ADVANCING women academic faculty in STEM careers: The role of critical HRD in supporting diversity and inclusion. Advances in Developing Human Resources, 21(1), 72-91.
Hutchins, Holly M., and Jamison V. Kovach. "ADVANCING women academic faculty in STEM careers: The role of critical HRD in supporting diversity and inclusion." Advances in Developing Human Resources 21.1 (2019): 72-91.
Copy Download .nbib Format: MLA
A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer.

Translational oncology

Voorneveld PW, Jacobs RJ, Kodach LL, Hardwick JC.
PMID: 25749173
Transl Oncol. 2015 Feb;8(1):18-24. doi: 10.1016/j.tranon.2014.11.003.

AIM: SMAD4 immunohistochemistry is considered a valuable prognostic marker in colorectal cancer, but individual studies have often been small and the results variable. A meta-analysis could potentially clarify these findings.METHODS: In September 2014, a Pubmed and Google Scholar search...

Cite
Voorneveld PW, Jacobs RJ, Kodach LL, et al. A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer. Transl Oncol. 2015;8(1):18-24doi: 10.1016/j.tranon.2014.11.003.
Voorneveld, P. W., Jacobs, R. J., Kodach, L. L., & Hardwick, J. C. (2015). A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer. Translational oncology, 8(1), 18-24. https://doi.org/10.1016/j.tranon.2014.11.003
Voorneveld, Philip W, et al. "A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer." Translational oncology vol. 8,1 (2015): 18-24. doi: https://doi.org/10.1016/j.tranon.2014.11.003
Voorneveld PW, Jacobs RJ, Kodach LL, Hardwick JC. A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer. Transl Oncol. 2015 Feb;8(1):18-24. doi: 10.1016/j.tranon.2014.11.003. PMID: 25749173; PMCID: PMC4350636.
Copy Download .nbib Format: NLM
Genotype-environment associations support a mosaic hybrid zone between two tidal marsh birds.

Ecology and evolution

Walsh J, Rowe RJ, Olsen BJ, Shriver WG, Kovach AI.
PMID: 26811792
Ecol Evol. 2015 Dec 29;6(1):279-94. doi: 10.1002/ece3.1864. eCollection 2016 Jan.

Local environmental features can shape hybrid zone dynamics when hybrids are bounded by ecotones or when patchily distributed habitat types lead to a corresponding mosaic of genotypes. We investigated the role of marsh-level characteristics in shaping a hybrid zone...

Cite
Walsh J, Rowe RJ, Olsen BJ, et al. Genotype-environment associations support a mosaic hybrid zone between two tidal marsh birds. Ecol Evol. 2015;6(1):279-94doi: 10.1002/ece3.1864.
Walsh, J., Rowe, R. J., Olsen, B. J., Shriver, W. G., & Kovach, A. I. (2016). Genotype-environment associations support a mosaic hybrid zone between two tidal marsh birds. Ecology and evolution, 6(1), 279-94. https://doi.org/10.1002/ece3.1864
Walsh, Jennifer, et al. "Genotype-environment associations support a mosaic hybrid zone between two tidal marsh birds." Ecology and evolution vol. 6,1 (2016): 279-94. doi: https://doi.org/10.1002/ece3.1864
Walsh J, Rowe RJ, Olsen BJ, Shriver WG, Kovach AI. Genotype-environment associations support a mosaic hybrid zone between two tidal marsh birds. Ecol Evol. 2015 Dec 29;6(1):279-94. doi: 10.1002/ece3.1864. eCollection 2016 Jan. PMID: 26811792; PMCID: PMC4716509.
Copy Download .nbib Format: NLM
Development of diagnostic microsatellite markers from whole-genome sequences of Ammodramus sparrows for assessing admixture in a hybrid zone.

Ecology and evolution

Kovach AI, Walsh J, Ramsdell J, Kelley Thomas W.
PMID: 26078861
Ecol Evol. 2015 Jun;5(11):2267-83. doi: 10.1002/ece3.1514. Epub 2015 May 13.

Studies of hybridization and introgression and, in particular, the identification of admixed individuals in natural populations benefit from the use of diagnostic genetic markers that reliably differentiate pure species from each other and their hybrid forms. Such diagnostic markers...

Cite
Kovach AI, Walsh J, Ramsdell J, et al. Development of diagnostic microsatellite markers from whole-genome sequences of Ammodramus sparrows for assessing admixture in a hybrid zone. Ecol Evol. 2015;5(11):2267-83doi: 10.1002/ece3.1514.
Kovach, A. I., Walsh, J., Ramsdell, J., & Kelley Thomas, W. (2015). Development of diagnostic microsatellite markers from whole-genome sequences of Ammodramus sparrows for assessing admixture in a hybrid zone. Ecology and evolution, 5(11), 2267-83. https://doi.org/10.1002/ece3.1514
Kovach, Adrienne I, et al. "Development of diagnostic microsatellite markers from whole-genome sequences of Ammodramus sparrows for assessing admixture in a hybrid zone." Ecology and evolution vol. 5,11 (2015): 2267-83. doi: https://doi.org/10.1002/ece3.1514
Kovach AI, Walsh J, Ramsdell J, Kelley Thomas W. Development of diagnostic microsatellite markers from whole-genome sequences of Ammodramus sparrows for assessing admixture in a hybrid zone. Ecol Evol. 2015 Jun;5(11):2267-83. doi: 10.1002/ece3.1514. Epub 2015 May 13. PMID: 26078861; PMCID: PMC4461426.
Copy Download .nbib Format: NLM
A Comparison Between Etomidate and Methohexital for Anesthesia in ECT.

Convulsive therapy

Kovac AL, Pardo M.
PMID: 11941157
Convuls Ther. 1992;8(2):118-125.

Twenty patients were enrolled in a prospective, randomized, open vial, within-patient, crossover design study of methohexital and etomidate anesthesia for electroconvulsive therapy (ECT). Methohexital (1.0 mg/kg) and etomidate (0.3 mg/kg) were each given for two ECTs. While there were...

Cite
Kovac AL, Pardo M. A Comparison Between Etomidate and Methohexital for Anesthesia in ECT. Convuls Ther. 1992;8(2):118-125
Kovac, A. L., & Pardo, M. (1992). A Comparison Between Etomidate and Methohexital for Anesthesia in ECT. Convulsive therapy, 8(2), 118-125.
Kovac, Anthony L., and Pardo, Manuel. "A Comparison Between Etomidate and Methohexital for Anesthesia in ECT." Convulsive therapy vol. 8,2 (1992): 118-125.
Kovac AL, Pardo M. A Comparison Between Etomidate and Methohexital for Anesthesia in ECT. Convuls Ther. 1992;8(2):118-125. PMID: 11941157.
Copy Download .nbib Format: NLM
NATO Science.

Science (New York, N.Y.)

Kovach EG.
PMID: 17800362
Science. 1969 Apr 25;164(3878):375-6. doi: 10.1126/science.164.3878.375.

No abstract available.

Cite
Kovach EG. NATO Science. Science. 1969;164(3878):375-6doi: 10.1126/science.164.3878.375.
Kovach, E. G. (1969). NATO Science. Science (New York, N.Y.), 164(3878), 375-6. https://doi.org/10.1126/science.164.3878.375
Kovach, E G. "NATO Science." Science (New York, N.Y.) vol. 164,3878 (1969): 375-6. doi: https://doi.org/10.1126/science.164.3878.375
Kovach EG. NATO Science. Science. 1969 Apr 25;164(3878):375-6. doi: 10.1126/science.164.3878.375. PMID: 17800362.
Copy Download .nbib Format: NLM
Thriving in an academic environment.

Research in nursing & health

Kovach CR.
PMID: 15042633
Res Nurs Health. 2004 Apr;27(2):73-4. doi: 10.1002/nur.20010.

No abstract available.

Cite
Kovach CR. Thriving in an academic environment. Res Nurs Health. 2004;27(2):73-4doi: 10.1002/nur.20010.
Kovach, C. R. (2004). Thriving in an academic environment. Research in nursing & health, 27(2), 73-4. https://doi.org/10.1002/nur.20010
Kovach, Christine R. "Thriving in an academic environment." Research in nursing & health vol. 27,2 (2004): 73-4. doi: https://doi.org/10.1002/nur.20010
Kovach CR. Thriving in an academic environment. Res Nurs Health. 2004 Apr;27(2):73-4. doi: 10.1002/nur.20010. PMID: 15042633.
Copy Download .nbib Format: NLM
Caring for the Whole Person with HIV: Mind, Body, and Spirit.

The Permanente journal

Kovach DA.
PMID: 21364816
Perm J. 2008;12(2):69-71. doi: 10.7812/tpp/07-137.

No abstract available.

Cite
Kovach DA. Caring for the Whole Person with HIV: Mind, Body, and Spirit. Perm J. 2008;12(2):69-71doi: 10.7812/tpp/07-137.
Kovach, D. A. (2008). Caring for the Whole Person with HIV: Mind, Body, and Spirit. The Permanente journal, 12(2), 69-71. https://doi.org/10.7812/tpp/07-137
Kovach, Drew A. "Caring for the Whole Person with HIV: Mind, Body, and Spirit." The Permanente journal vol. 12,2 (2008): 69-71. doi: https://doi.org/10.7812/tpp/07-137
Kovach DA. Caring for the Whole Person with HIV: Mind, Body, and Spirit. Perm J. 2008;12(2):69-71. doi: 10.7812/tpp/07-137. PMID: 21364816; PMCID: PMC3042295.
Copy Download .nbib Format: NLM
Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures.

Forensic toxicology

Kevin RC, Kovach AL, Lefever TW, Gamage TF, Wiley JL, McGregor IS, Thomas BF.
PMID: 30705707
Forensic Toxicol. 2019 Jan;37(1):17-26. doi: 10.1007/s11419-018-0430-0. Epub 2018 Jun 28.

PURPOSE: The use of novel synthetic cannabinoids as intoxicants continues in spite of associated health risks. These compounds are typically smoked or vaporized, but many synthetic cannabinoids contain thermally labile chemical moieties. This study investigated the thermal stability six...

Cite
Kevin RC, Kovach AL, Lefever TW, et al. Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures. Forensic Toxicol. 2018;37(1):17-26doi: 10.1007/s11419-018-0430-0.
Kevin, R. C., Kovach, A. L., Lefever, T. W., Gamage, T. F., Wiley, J. L., McGregor, I. S., & Thomas, B. F. (2019). Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures. Forensic toxicology, 37(1), 17-26. https://doi.org/10.1007/s11419-018-0430-0
Kevin, Richard C, et al. "Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures." Forensic toxicology vol. 37,1 (2019): 17-26. doi: https://doi.org/10.1007/s11419-018-0430-0
Kevin RC, Kovach AL, Lefever TW, Gamage TF, Wiley JL, McGregor IS, Thomas BF. Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures. Forensic Toxicol. 2019 Jan;37(1):17-26. doi: 10.1007/s11419-018-0430-0. Epub 2018 Jun 28. PMID: 30705707; PMCID: PMC6349387.
Copy Download .nbib Format: NLM
Dissociated Optic Nerve Fiber Layer Imaged with OCT Angiography.

Ophthalmology. Retina

Kovach JL.
PMID: 31047190
Ophthalmol Retina. 2018 Dec;2(12):1195. doi: 10.1016/j.oret.2018.09.011.

No abstract available.

Cite
Kovach JL. Dissociated Optic Nerve Fiber Layer Imaged with OCT Angiography. Ophthalmol Retina. 2018;2(12):1195doi: 10.1016/j.oret.2018.09.011.
Kovach, J. L. (2018). Dissociated Optic Nerve Fiber Layer Imaged with OCT Angiography. Ophthalmology. Retina, 2(12), 1195. https://doi.org/10.1016/j.oret.2018.09.011
Kovach, Jaclyn L. "Dissociated Optic Nerve Fiber Layer Imaged with OCT Angiography." Ophthalmology. Retina vol. 2,12 (2018): 1195. doi: https://doi.org/10.1016/j.oret.2018.09.011
Kovach JL. Dissociated Optic Nerve Fiber Layer Imaged with OCT Angiography. Ophthalmol Retina. 2018 Dec;2(12):1195. doi: 10.1016/j.oret.2018.09.011. PMID: 31047190.
Copy Download .nbib Format: NLM
Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study.

Biomedical optics express

Jelvehgaran P, Alderliesten T, Georgiou G, Meijer SL, Bloemen PR, Kodach LL, van Laarhoven HWM, van Berge Henegouwen MI, Hulshof MCCM, Rasch CRN, van Leeuwen TG, de Boer JF, de Bruin M, van Herk M.
PMID: 30615728
Biomed Opt Express. 2018 Aug 14;9(9):4196-4216. doi: 10.1364/BOE.9.004196. eCollection 2018 Sep 01.

Treatment of resectable esophageal cancer includes neoadjuvant chemo-radiation therapy (nCRT) followed by esophagectomy in operable patients. High-risk surgery may have been avoided in patients with a pathological complete response (pCR). We investigated the feasibility of optical coherence tomography (OCT)...

Cite
Jelvehgaran P, Alderliesten T, Georgiou G, et al. Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study. Biomed Opt Express. 2018;9(9):4196-4216doi: 10.1364/BOE.9.004196.
Jelvehgaran, P., Alderliesten, T., Georgiou, G., Meijer, S. L., Bloemen, P. R., Kodach, L. L., van Laarhoven, H. W. M., van Berge Henegouwen, M. I., Hulshof, M. C. C. M., Rasch, C. R. N., van Leeuwen, T. G., de Boer, J. F., de Bruin, M., & van Herk, M. (2018). Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study. Biomedical optics express, 9(9), 4196-4216. https://doi.org/10.1364/BOE.9.004196
Jelvehgaran, Pouya, et al. "Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study." Biomedical optics express vol. 9,9 (2018): 4196-4216. doi: https://doi.org/10.1364/BOE.9.004196
Jelvehgaran P, Alderliesten T, Georgiou G, Meijer SL, Bloemen PR, Kodach LL, van Laarhoven HWM, van Berge Henegouwen MI, Hulshof MCCM, Rasch CRN, van Leeuwen TG, de Boer JF, de Bruin M, van Herk M. Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study. Biomed Opt Express. 2018 Aug 14;9(9):4196-4216. doi: 10.1364/BOE.9.004196. eCollection 2018 Sep 01. PMID: 30615728; PMCID: PMC6157785.
Copy Download .nbib Format: NLM
Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.

Molecular cancer therapeutics

Mirzapoiazova T, Xiao G, Mambetsariev B, Nasser MW, Miaou E, Singhal SS, Srivastava S, Mambetsariev I, Nelson MS, Nam A, Behal A, Atri P, Muschen M, Tissot FLH, Miser J, Kovach JS, Sattler M, Batra SK, Kulkarni P, Salgia R.
PMID: 34253596
Mol Cancer Ther. 2021 Oct;20(10):1820-1835. doi: 10.1158/1535-7163.MCT-21-0013. Epub 2021 Jul 12.

Protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in the regulation of apoptosis, proliferation, and DNA-damage response, is overexpressed in many cancers, including small cell lung cancer (SCLC). Here we report that LB100, a small molecule inhibitor of PP2A,...

Cite
Mirzapoiazova T, Xiao G, Mambetsariev B, et al. Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer. Mol Cancer Ther. 2021;20(10):1820-1835doi: 10.1158/1535-7163.MCT-21-0013.
Mirzapoiazova, T., Xiao, G., Mambetsariev, B., Nasser, M. W., Miaou, E., Singhal, S. S., Srivastava, S., Mambetsariev, I., Nelson, M. S., Nam, A., Behal, A., Atri, P., Muschen, M., Tissot, F. L. H., Miser, J., Kovach, J. S., Sattler, M., Batra, S. K., Kulkarni, P., & Salgia, R. (2021). Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer. Molecular cancer therapeutics, 20(10), 1820-1835. https://doi.org/10.1158/1535-7163.MCT-21-0013
Mirzapoiazova, Tamara, et al. "Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer." Molecular cancer therapeutics vol. 20,10 (2021): 1820-1835. doi: https://doi.org/10.1158/1535-7163.MCT-21-0013
Mirzapoiazova T, Xiao G, Mambetsariev B, Nasser MW, Miaou E, Singhal SS, Srivastava S, Mambetsariev I, Nelson MS, Nam A, Behal A, Atri P, Muschen M, Tissot FLH, Miser J, Kovach JS, Sattler M, Batra SK, Kulkarni P, Salgia R. Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer. Mol Cancer Ther. 2021 Oct;20(10):1820-1835. doi: 10.1158/1535-7163.MCT-21-0013. Epub 2021 Jul 12. PMID: 34253596; PMCID: PMC8722383.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 123 entries